Amgen cash flow 2004-2021

In 2021, cash flow came to some 9.26 billion U.S. dollars. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. This statistic shows Amgen's cash flow from operating activities from 2004 to 2021.

Amgen's cash flow from 2004 to 2021* (in million U.S. dollars)

Characteristic	Cash flow in million U.S. dollars
2021	9,261
2020	10,497
2019	9,150
2018	11,296
2017	11,177
2016	10,354
2015	9,731
2014	8,952
2013	6,291
2012	5,882
2011	5,119
2010	5,787
2009	6,336
2008	5,988
2007	5,401
2006	5,389
2005	4,911
2004	3,697

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2022

More information

Region

Worldwide

Survey time period

2004 to 2021

Supplementary notes

* Net cash provided by operating activities. Operating cash flow is an economic indicator that reflects the portion of cash flow that comes from the ordinary activities of an enterprise. The cash flow itself is an economic measurement that shows the net inflow of funds generated from the sales activities and other ongoing activities during a period and thus allows an assessment about the financial health of a company.
Pre-2019 values were taken from older annual financial reports.

Citation formats